Karyopharm Completes Patient Recruitment In Phase 3 SIENDO Study Of Selinexor In Patients With Endometrial Cancer by | Dec 2, 2021 | Extra Jobs | 0 comments Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Recent Comments